U.S. approval of Merck cancer immunotherapy expected soon

cp418
cp418 Member Posts: 7,079
edited August 2014 in Clinical Trials, Research News, Podcasts, and Study Results

http://www.reuters.com/article/2014/08/25/us-merck-cancer-fda-idUSKBN0GP0VU20140825

Exclusive: U.S. approval of Merck cancer immunotherapy expected soon

Companies including Bristol-Myers Squibb, Roche Holding AG and AstraZeneca Plc are racing to develop similar treatments for a variety of cancers. Some analysts expect the new class could generate more than $30 billion in annual sales worldwide by 2025.

· Share on FacebookShare on Twitter

Comments

  • Meow13
    Meow13 Member Posts: 4,859
    edited August 2014


    It's about time, notice they were talking about bladder, lung and skin cancer but it is a step in the right direction. We need drugs other than traditional chemo therapy that target the tumors and help the immune system target them as well.

    Interesting this is in the financial news stock going up on this news?

    · Share on FacebookShare on Twitter
  • MusicLover
    MusicLover Member Posts: 4,225
    edited August 2014

    I didn't read the article thoroughly but it looks like good news.  Now we need some mention of breast cancer immunotherapy on it's way...

    It is hitting the financial news because they want investors, I believe.  It is becoming a bit of a race, as cp418 has said, so we should be seeing things happening faster and faster (I hope so, anyway).

    Great post cp418!

    PS - Keep the prayers coming for a cure and for any new drugs which can help us.


    · Share on FacebookShare on Twitter

Categories